IP Library Patent Application 13076665
Patent Application
App. No. 13/076,665

ADJUSTABLE CHROMOPHORE COMPOUNDS AND MATERIALS INCORPORATING SUCH COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/076,665
Abstract

The present invention is directed to adjustable chromophore compounds and materials (e.g., ophthalmic lens materials) incorporating those compounds. The adjustable chromophore compounds include a chemical moiety that structurally changes upon exposure to predetermined electromagnetic radiation (e.g., two photon radiation) as well as lens materials, particularly intraocular lens materials that incorporate those compounds.

Claims (62)

1 . An adjustable chromophore comprising:

a compound of the formula:

B—X;

wherein:

v) B is a base chromophore compound; and

vi) X is an adjustable chemical moiety that forms a remaining chemical moiety (C) upon exposure to predetermined electromagnetic radiation thereby forming the compound:

B—C;

vii) the compound B—C provided greater light absorption than the compound B—X; and

viii) the remaining chemical moiety (C) includes a conjugated double bond.

2 . A chromophore as in claim 1 wherein the base chromophore compound is selected from the group consisting of benzotriazoles, benzophenones, azo dyes and cinnamate esters.

3 . A chromophore as in claim 2 wherein the base chromophore compound is a benzotriazole.

4 . A chromophore as in claim 1 wherein the compound B—C absorbs a significant amount of UV light, blue light or both.

5 . A chromophore as in claim 3 wherein the compound B—C absorbs a significant amount of blue light.

6 . A chromophore as in claim 1 wherein the adjustable chemical moiety X is a cyclic moiety.

7 . A chromophore as in claim 1 wherein the adjustable chemical moiety X is dicyclopentadiene.

8 . A lens comprising:

a polymeric material; and

the adjustable chromophore compound of claim 1 distributed within the polymeric material;

wherein the material can absorb light at progressively greater wavelengths as greater amounts of the compound B—C are formed from the adjustable compound B—X.

9 . A method of adjusting a lens in vivo or in vitro comprising:

directing the predetermined electromagnetic radiation at the polymeric material of claim 8 to form the compound B—C either prior to or after implantation of the lens in the eye.

10 . An adjustable chromophore system, comprising:

a compound of the formula:

B—X or B—C

as part of the reactive system:

B—X⇄B—C

wherein:

i) B is a base chromophore compound;

ii) X is an adjustable chemical moiety that forms remaining chemical moiety (C) upon exposure to first predetermined electromagnetic radiation thereby forming the compound B—C;

iii) the compound B—C provides greater light absorption than the compound B—X;

iv) the remaining chemical moiety (C) includes a conjugated double bond; and

v) optionally, the compound B—C forms the compound B—X upon exposure to second predetermined electromagnetic radiation either with or without the aid of a separable group (S).

11 . A system as in claim 10 wherein the base chromophore compound is selected from the group consisting of benzotriazoles, benzophenones, azo dyes and cinnamate esters.

12 . A system as in claim 11 wherein the base chromophore compound is a benzotriazole.

13 . A system as in claim 10 wherein the compound B—C absorbs a significant amount of UV light, blue light or both.

14 . A system as in claim 10 wherein the compound B—C absorbs a significant amount of blue light.

15 . A system as in claim 10 wherein the adjustable chemical moiety X is a cyclic moiety.

16 . A system as in claim 10 wherein the adjustable chemical moiety X is dicyclopentadiene.

17 . A lens comprising:

a polymeric material; and

the adjustable chromophore system of claim 10 distributed within the polymeric material.

18 . A method of adjusting a lens in vivo or in vitro comprising:

directing the predetermined first or second electromagnetic radiation at the lens of claim 17 to form the compound B—C or B—X either prior to or after implantation of the lens in the eye.

19 . An adjustable chromophore system, comprising:

a compound of the formula:

B—X or B—C

as part of the reactive system:

B—X⇄B—C

wherein:

i) B is a base chromophore compound;

ii) X is an adjustable chemical moiety that forms remaining chemical moiety (C) upon exposure to first predetermined electromagnetic radiation thereby forming the compound B—C;

iii) the compound B—C provides greater light absorption than the compound B—X;

iv) the remaining chemical moiety (C) includes a conjugated double bond;

v) the compound B—C forms the compound B—X upon exposure to second predetermined electromagnetic radiation either with or without the aid of a separable group (S);

vi) the base chromophore compound is selected from the group consisting of benzotriazoles, benzophenones, azo dyes and cinnamate esters;

vii) the compound B—C absorbs a significant amount of UV light, blue light or both; and

viii) the adjustable chemical moiety X is a cyclic moiety.

20 . A lens comprising:

a polymeric material; and

the adjustable chromophore system of claim 19 distributed within the polymeric material.

21 . A method of adjusting a lens in vivo or in vitro comprising:

directing the predetermined first or second electromagnetic radiation at the lens of claim 20 to form the compound B—C or B—X either prior to or after implantation of the lens in the eye.

Assignments (2)
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2011
From: WEINSCHENK, JOSEPH I., III
To: ALCON, INC.
Reel/Frame 026053/0401 →